Apotex, a Canadian drugmaker, won approval to make and sell semaglutide in Canada. This adds another manufacturer of the weight-loss drug to the market.

• •Apotex won Canadian approval for semaglutide
• •Adds another semaglutide maker to the Canadian market

Apotex got approval from Health Canada to sell a generic copy of Ozempic (semaglutide), the popular weight-loss and diabetes drug. Generic versions are cheaper than the brand-name drug, which could help more people afford the medication.

• •Health Canada approved Apotex's generic version of Ozempic (semaglutide)
• •The drug is used for diabetes and weight loss

Orbicular and Apotex won approval from Health Canada to sell a generic copy of semaglutide injection (the active ingredient in Ozempic). This is a cheaper version of the weight-loss and diabetes drug.

• •Health Canada approved a generic semaglutide injection
• •Orbicular partnered with Apotex on the product
• •Generic copies the active ingredient in Ozempic

Apotex, a Canadian drug maker, got approval to sell a generic copy of Ozempic (semaglutide), a popular weight-loss and diabetes drug. Apotex is the first Canadian company to win this approval from Health Canada.

• •Health Canada approved Apotex's generic version of Ozempic (semaglutide)
• •Apotex is the first Canadian company to win this approval
• •The drug is used for weight loss and diabetes

Apotex, a Canadian drugmaker, got approval to sell a generic copy of Ozempic (semaglutide), a popular weight-loss and diabetes drug. Apotex is the first Canadian company to win this approval from Health Canada, the country's medicine regulator.

• •Apotex won Health Canada approval for a generic version of Ozempic (semaglutide).
• •Apotex is the first Canadian-based company to get this generic approval.